Streetbeat News

Analyst Ratings

CHGG

Chegg (NYSE:CHGG) has received indifferent ratings from five analysts in the last quarter. The average 12-month price target for Chegg over the last three months is $12.8, an increase of 8.47% from the previous average price target of $11.80.

Portfolio Pulse from Benzinga Insights

October 19, 2023 | 9:00 pm

NTST

Over the past 3 months, 4 analysts have published their opinion on Netstreit (NYSE:NTST) stock. The average price target is $15.75, implying an upside from the current price of $13.81. This average has decreased by 23.17% from the previous average price target of $20.50.

Portfolio Pulse from Benzinga Insights

October 19, 2023 | 9:00 pm

NTRS

Northern Trust (NASDAQ:NTRS) has received 3 somewhat bullish and 6 indifferent analyst ratings in the last quarter. The average 12-month price target for the company is $81.67, a 9.48% decrease from the previous average of $90.22.

Portfolio Pulse from Benzinga Insights

October 19, 2023 | 9:00 pm

WERN

Werner Enterprises (NASDAQ:WERN) has received mixed analyst ratings in the last quarter, with 1 bullish, 1 somewhat bullish, 4 indifferent, and 1 somewhat bearish. The average 12-month price target for the company is $47.29, a decrease of 6.74% from the previous average of $50.71.

Portfolio Pulse from Benzinga Insights

October 19, 2023 | 9:00 pm

MRK

A significant bullish stance has been taken on Merck & Co (NYSE:MRK) as evidenced by unusual options activity. The options scanner at Benzinga spotted 14 uncommon trades, with a split sentiment of 64% bullish and 35% bearish. The whales have been targeting a price range from $95.0 to $120.0 for Merck & Co over the last 3 months. The current price of MRK is down -1.53% at $100.43. Analysts have mixed opinions, with Cantor Fitzgerald and Truist Securities downgrading their actions but maintaining high price targets.

Portfolio Pulse from Benzinga Insights

October 19, 2023 | 8:46 pm

NVTA

Invitae (NYSE:NVTA), a medical genetics company, has appointed Dr. David Sholehvar as its new Chief Operating Officer, effective from November 13, 2023. Dr. Sholehvar has a 25-year track record in healthcare business leadership, having held roles at NeoGenomics Inc., Dynex Technologies, Quest Diagnostics, and Johnson & Johnson. As part of his hiring, Invitae is granting 850,000 restricted stock units to Dr. Sholehvar under its 2015 Stock Incentive Plan.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 8:35 pm

HPE

Hewlett Packard Enterprise (HPE) has provided an outlook at its Securities Analyst Meeting, forecasting a 2-4% revenue growth in constant currency by 2024. The company also predicts a non-GAAP EPS of $1.82-$2.02, which is lower than the estimated $2.14.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 8:33 pm

AMT

A large investor has taken a bullish stance on American Tower (NYSE:AMT), as evidenced by a significant position in the company's options. The sentiment among these big-money traders is split 50% bullish and 50% bearish. The price target for AMT, based on volume and open interest, is between $150 and $200. The current price of AMT is $159.43, down 2.06%. Analysts from Citigroup, JP Morgan, Morgan Stanley, and Wells Fargo have maintained their positive ratings on AMT.

Portfolio Pulse from Benzinga Insights

October 19, 2023 | 8:32 pm

BYND

Beyond Meat, Inc. (NASDAQ:BYND) shares fell after Mizuho analyst John Baumgartner downgraded the stock from Neutral to Underperform and announced a $5 price target. The analyst cited a lack of product innovation, need for new capital due to cash burn, tightening liquidity, and lack of increased consumption for the company's products as reasons for the downgrade. The stock is down 56.44% over the past six months.

Portfolio Pulse from Ryan Gustafson

October 19, 2023 | 8:25 pm

MCB

Metropolitan Bank Holding (NYSE:MCB) reported Q3 earnings of $1.97 per share, a decrease of 11.66% YoY. The company also reported quarterly sales of $60.07M, missing the analyst consensus estimate of $61.09M by 1.67%.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 8:16 pm